ERBB2 and breast cancer: The SK-BR-3 cell specific aptamer sk6Ea with a Kd 49.32 ± 14.53 nM was able to distinguish patient derived HER2-enriched breast cancer tissue from triple-negative, luminal A and B subtype and normal tissue.